London, UK – November 3rd 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that HRS Home Health (HRS) is expanding their use of Wanda to all of their home health patients. This follows a successful trial evaluation involving high-risk, co-morbid Congestive Heart Failure patients.
Commenting on the news, NetScientific’s Chief Executive Officer and Chairman of Wanda, Francois R. Martelet said: “We are pleased to announce that HRS will be expanding its use of Wanda to all patients. We are also delighted to announce that HRS reported a 72% lower readmission rate for patients using Wanda, in addition to a high compliancy of 74%. We believe the data demonstrates Wanda’s great technical capabilities, in addition to Wanda’s ability to be integrated into clinician’s workflow, both changing lives and reducing cost.”
NetScientific holds a 61% stake on a fully diluted basis in Wanda.
For more information, please contact:
François R. Martelet, M.D., CEO
Ian Postlethwaite, CFO
Tel: +44 (0)20 3514 1800
Consilium Strategic Communications
Mary-Jane Elliott Jessica Hodgson /
Chris Welsh / Laura Thornton
Tel: +44 (0)20 3709 5700
Stifel Nicolaus Europe Limited (NOMAD and Broker)
Jonathan Senior / David Arch / Ben Maddison
Tel: +44 (0) 20 7710 7600
Health Resource Solutions (HRS Home Health) is using Wanda to increase patient compliance while decreasing readmissions
Summary: Health Resource Solutions is expanding their use of Wanda to all of their home health patients
After completing a successful program targeting high-risk, comorbid Congestive Heart Failure patients, Health Resource Solutions (HRS) is expanding their use of Wanda to HRS home health patients. HRS is using Wanda’s machine learning and clinical analytics in unison with patient centered goals and HRS’s transition of care guidelines that tie into clinical pathways to deliver better care for patients. The HRS Model concentrates on utilizing technology and services to provide the right care at the right time for the patient. HRS has increased patient compliance with individual care plans that include patient’s goal. The integration of Wanda’s technology with care interventions has decreased readmissions and costs of care. HRS is expanding this approach of integrating technology with interventions to its entire patient population to improve patient outcomes at lower costs.
HRS has found that HF patients that use Wanda have a 72% less probability of getting readmitted to the hospital. Furthermore, patients on Wanda showed an average compliancy of 74%, measured by daily interaction with the Wanda technology and adhering to their care plan.
Glenn Steigbigel, HRS CEO, noted: “We are very excited by the results we were able to achieve for our patients by reducing readmissions to 4.5% and high engagement and compliancy of those patient. Wanda has enabled us to deliver better care without increasing the workload for our clinicians, who are more effective with patients that are more engaged during the recovery process at home. Wanda is allowing us to identify variances during care delivery so that we can apply prevention and intervention techniques. By expanding Wanda, HRS continues to change lives by improving value for our patients and the clinicians that care for them. ”
“Wanda is all about applying modern software applications powered by analytics, data science and deep healthcare knowledge in a meaningful, personal way that is unique to each patient and in the way nurses, doctors and the full care team can believe and then act on the information provided.” Said Wanda CEO Foad Dabiri.
HRS is the largest privately owned high-tech nursing and rehabilitation home health agency in Chicago, IL. Since 2005, HRS has integrated data and technologies with home health services to measure and increase outcomes and value for patients, caregivers and clinicians. More information about HRS can be found at www.healthrs.net
Wanda is dedicated to advancing the effectiveness and efficiency of medicine by using machine learning and modern software applications, enabling care providers to intelligently monitor, communicate with and manage their patients leading to improved outcomes and efficiencies. More information about Wanda can be found at www.yourwanda.com.
NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net
San Francisco-based Wanda is dedicated to advancing the effectiveness and efficiency of medicine by using machine learning in place of conventional technologies and by enabling clinicians to make more informed care decisions. Wanda recognizes that remote monitoring and algorithms cannot save lives or reduce hospitalizations unless the individual and their caregivers are promptly informed and highly engaged. Through the collaboration of data science and applied medical research, Wanda has proven that its inline analytics predict preventable events much better than conventional methods. Wanda serves as a diligent companion, providing encouragement and intelligent visual guidance that simplifies and improves lives, while simultaneously helping organizations reduce their care delivery costs. Wanda is a NetScientific portfolio company. More information about Wanda can be found at www.yourwanda.com.